Literature DB >> 31772379

Initial treatment of macular oedema due to central retinal vein occlusion-which anti-VEGF agent to choose?

Elad Moisseiev1,2, Anat Loewenstein3,4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31772379      PMCID： PMC7002686          DOI： 10.1038/s41433-019-0706-6

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN： 0950-222X            Impact factor:   3.775


× No keyword cloud information.
  1 in total

1.  Five-year visual acuity outcomes and injection patterns in patients with pro-re-nata treatments for AMD, DME, RVO and myopic CNV.

Authors:  Thomas Wecker; Christoph Ehlken; Anima Bühler; Clemens Lange; Hansjürgen Agostini; Daniel Böhringer; Andreas Stahl
Journal:  Br J Ophthalmol       Date:  2016-05-23       Impact factor: 4.638
  1 in total
  1 in total

1.  Efficacy of single-dose intravitreal dexamethasone implantation for retinal vein occlusion patients with refractory macular edema: A systematic review and meta-analysis.

Authors:  Qiongzhen Yuan; Yunxia Gao; Yilin Liu; Hanyue Xu; Tong Wang; Ming Zhang
Journal:  Front Pharmacol       Date:  2022-09-28       Impact factor: 5.988
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.